论文部分内容阅读
间质性肺疾病(Interstitial Lung Disease LID)是由一组导质性疾病组成,它们在临床、X线、呼吸生理和病理形态各方面具有相类似的表现,并常走向一个共同的结局——肺间质纤维化,过去认为是一种较罕见的疾病,近十年来,一方面由于发病率的增高,如1977年美国估计每年约有89,000名住院患者患慢性间质性肺疾病;另一方面在对本病的研究观察过程中将涉及诸如肺的防御机制、免疫反应、修复过程和肺内生物活性物质的代谢等重要
Interstitial Lung Disease (LID) is a group of neuropathic disorders that perform similarly in clinical, X-ray, respiratory physiology, and pathology and often lead to a common outcome - Pulmonary interstitial fibrosis, a rarer disease in the past, has been characterized by an increase in incidence over the last decade, as estimated by the United States in 1977 with an estimated 89,000 inpatients with chronic interstitial lung disease each year; Aspects of the study on the disease will involve such important mechanisms as lung defense mechanisms, immune responses, repair processes, and metabolism of bioactive substances in the lungs